Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational and life science research. The Quantabio team leverages decades of experience in developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical cloning, PCR, qPCR and Next-Generation Sequencing (NGS) based applications. Based in Beverly, Mass., Quantabio offers a growing portfolio of products through its international sales operations, as well as a global network of distributors and commercial service providers.
Quantabio Reagent Technologies
Stringent enzyme activation control with AccuStart technology
Reaction setup and multi-day storage at ambient temperature
ToughMix reagents withstand a broad spectrum of PCR inhibitors
Reliable assay performance with challenging starting materials and crude extracts
Optimized to Improve Sequencing Performance & Economics
Comprehensive solutions for DNA fragmentation, library preperation, amplification and quantification
Novel formulations streamline NGS workflows reducing total turn-around time
Proprietary enzymes & buffer compositions improve library yields and sequencing results from low inputs
Legacy of Innovation
Quantabio has a legacy of pioneering market leading PCR & qPCR reagents including its’ early days starting out when the team developed Invitrogen’s SuperScript One-Step RT-PCR Kits, Platinum Taq and Bio-Rad’s iScript and iQ/iTaq Supermixes. Most recently, the brand has begun providing leading reagents solutions for cloning and NGS to complement the molecular biology portfolio for sample prep, cDNA synthesis, PCR and qPCR.